跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BUSCOPAN FORTE hyoscine butylbromide 20mg film-coated tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
BUSCOPAN FORTE hyoscine butylbromide 20mg film-coated tablet blister pack
Approved
STANDARD
BUSCOPAN FORTE hyoscine butylbromide 20mg film-coated tablet blister pack
Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
47785a874d8ac0ea
Company
Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
Type
Standard
Approval Details
Approval Id
47785a874d8ac0ea
Product Name
BUSCOPAN FORTE hyoscine butylbromide 20mg film-coated tablet blister pack
Artg Id
153552
Artg Name
BUSCOPAN FORTE hyoscine butylbromide 20mg film-coated tablet blister pack
Sponsor
Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare
Company Detail Path
/organization/sanofi-aventis-healthcare-pty-ltd
Artg Date
2008-07-09
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/0e26302fdf6e2c4f88763535ace95f48.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
47785a874d8ac0ea
Type
Standard
Back to TGA Approvals
